Lv5
818 积分 2025-03-21 加入
Therapy for mixed dyslipidaemia through ANGPTL3 inhibition
2天前
待确认
PCSK9 inhibitors in the management of atherosclerotic cardiovascular disease: Current clinical trials and future directions
2天前
已完结
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis
2天前
已完结
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
2天前
已完结
Beyond LDL
2天前
求助中
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
14天前
已完结
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept
25天前
已完结
The human liver‐specific proteome defined by transcriptomics and antibody‐based profiling
27天前
已完结
Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease
27天前
已完结
Fatty Liver in Pregnancy: Bridging the Gap Between Diagnosis and Treatment
27天前
已完结
An Ultrathin Membrane with Bubble‐Raft‐Inspired Single‐Layer Nanofibrous Networks for Efficient and Low‐Resistance Air Filtration
5个月前
已采纳
An in situ FTIR-DRIFTS study on CDRM over Co–Ce/ZrO2: Active surfaces and mechanistic features
5个月前
已采纳
Extremophiles as Plant Probiotics to Promote Germination and Alleviate Salt Stress in Soybean
6个月前
已采纳
Radiation resilience of Silicon-On-Insulator Vertical Super Thin Body (SOI VSTB) field-effect transistors: A TCAD simulation study on SEE effects
6个月前
已采纳
Do Overall Weight, Body Mass Index, or Clinically Significant Weight Changes Occur After Total Joint Arthroplasty? A Meta-Analysis of 60,837 Patients
6个月前
已采纳
Polyethylene glycol immunogenicity in nanomedicine
6个月前
已采纳
Polyethylene glycol immunogenicity in nanomedicine
6个月前
已采纳
Polyethylene glycol immunogenicity in nanomedicine
6个月前
已采纳
皖公网安备34019202002308
